Krivox operates a cross-border advisory platform for medical second opinions, connecting patients in emerging markets with vetted US board-certified physicians.
Patients in emerging markets often lack a structured way to access specialist input on complex cases. Apex Opinion connects these patients with vetted US board-certified physicians who review medical records and prepare an advisory second opinion report. The platform is designed for cross-border care across geographies.
Specialist second opinions can help refine clinical understanding, but most patients in emerging markets have no structured way to access one. Current pathways are fragmented, informal, and inconsistent.
Patients submit medical records. The platform matches the case to a vetted US board-certified specialist. The specialist reviews the materials and prepares a written advisory second opinion report, typically within 5 to 7 business days.
Patients upload their medical records securely. A US board-certified specialist on the Apex Opinion network reviews the case and prepares an advisory second opinion report, typically within 5 to 7 business days.
Interventional cardiologist and entrepreneur with deep domain expertise in structural heart disease and cardiology, widely regarded as a key opinion leader in the field. Mayo Clinic dual fellowship trained (Interventional Cardiology and Advanced Structural Heart), ABIM dual board-certified, with over 30 peer-reviewed publications in cardiovascular medicine. Principal Investigator on multiple FDA pivotal and IDE clinical trials and advises five leading medical technology companies. A recognized voice in the field, he has been featured across print and television media and has lectured at major national and international cardiovascular conferences. He identified and exposed a recurring gap: patients in emerging markets facing life-altering diagnoses had no structured access to US specialist review. Apex Opinion was built from that insight, combining clinical depth with a technology platform designed for scale, compliance, and operational rigor.
Two-time healthcare technology founder with successful exits in both companies. Founded and led iProcedures, an anesthesia EMR ranked #1 Best in KLAS for three consecutive years and deployed across 740+ hospitals nationwide. iProcedures was acquired by Clearlake Capital and is now part of Provation under Fortive (NYSE: FTV). Previously founded Arrowhead Technologies, acquired by Starlight Ventures. Built enterprise distribution through Allscripts/Altera and MEDITECH, reaching 19 of the top 20 US hospital systems. At Krivox, he advises on product architecture, regulatory-safe system design, and scaling the platform for international markets.
Apex Opinion is in development, with public launch planned for 2026. We are building a physician panel across core specialties.
Apex Opinion is building a selective panel of US board-certified specialists. We are selective by design: every physician on the panel reflects the clinical standard our users depend on. If you are accepted, you review cases remotely, on your own schedule, from anywhere. No overhead. No insurance paperwork. No payer negotiations. Just clinical work that pays well, deposited directly.